User's guide to JAK inhibitors in inflammatory bowel disease

Inflammatory bowel disease (IBD), such as ulcerative colitis (UC) and Crohn's disease (CD), are remitting and relapsing disorders of the gastrointestinal tract, highlighted by the dysregulation of pro- and anti-inflammatory mediators, which lead to mucosal damage. These conditions cause a signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiewak, Ted A., Patel, Anish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Medical Management of IBD Edited by Joana Torres and Ryan Ungaro
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920857/
https://www.ncbi.nlm.nih.gov/pubmed/35300073
http://dx.doi.org/10.1016/j.crphar.2022.100096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920857/
https://www.ncbi.nlm.nih.gov/pubmed/35300073
http://dx.doi.org/10.1016/j.crphar.2022.100096

Ejemplares similares